19 March 2014
This second Annual National Haematological PhD course, which took place on 13-14 March at Hindsgavl Slot, Middelfart, was offered by “Dansk Hæmatologisk Forskerskole Netværk” and provided by the Doctoral School of Clinical Science and Biomedicine, Aalborg University.
Head of course were Professor MSO Karen Dybkær, Aalborg University Hospital and Chief Molecular Biologist Niels Pallisgaard, Vejle Hospital, University of Southern Denmark.
Linn Rønlev Reinholdt attended this PhD course titled “Biomarkers in haematology”.
Experts within their fields gave lectures and related the most recent knowledge to the present clinical status and implementation.
The topics discussed were design and analysis of biomarker experiments, immunhistochemistry, cytology/cytogenetics, microarray gene expression profiling, next generation sequencing, methyleation analyses, flow cytometry, PCR analyses and standardizing PCR assays.
Please find programme here
Karen Dybkær attended the Annual Meeting at Danish Haematological Society at Hindsgavl on 14-15 March 2014.
16 September 2013
The annual haematological harvest meeting will be held in Aalborg on 27 September 2013.
Please find the programme here.
The meeting is sponsered by Roche a/s.
2 May 2013
Dansk Selskab for Cancerforskning will hold their annual meeting on 3 May, and Karen Dybkær, Malene Krag Kjeldsen, Sara Marques and Steffen Falgreen Larsen will attend the meeting.
4 July 2013
A PhD course with the title ” Translational Cancer Research – The Scientific Methodology, Technologies, Infrastructure and Clinical Validation Trials and Implementation” will be held on 12-14 November 2013. Please find the programme here.
Enrolment to the PhD course is done through Aalborg University’s “PhD moodle” https://phd.moodle.aau.dk/login/index.php
For further information about the Doctoral School in Medicine, Biomedical Science and Technology at Aalborg University, please use this link.
2 May 2013
Department of haematology, research section, will be represented at Forskningens Døgn by Alexander Schmitz, Helle Høholt and Anette Mai Tramm who will have a stand at Medicinerhuset, Aalborg University Hospital.
2 May 2013
Karen Dybkær and Malene Krag Kjeldsen participated in a complementary workshop in Copenhagen. They attended the course to learn about the majer features of Partek Genomics Suite, Partek Flow and Partek Pathway.
18 March 2013
Liesbeth, Sara and Steffen attended the first Annual National Haematological PhD course: “From Scientific Idea to New Targeted Therapy – how to commercialize science”, organized by the University of Southern Denmark. This 2-day course took place in March at the Hindsgavl Slot in Middelfart. Commercialization of scientific projects was under discussion, and the development of a new monoclonal antibody with anti-neoplastic properties was presented, spanning the process from the identification of a cellular target through clinical evaluation to the final European Medicines Agency registration. All students were asked to discuss the commercial potential of their project.
Sara presented the poster “Functional analysis of microRNA-dependent chemosensitivity in B-cell cancers by lentiviral transduction in human cancer B-cell lines”,Steffen presented the poster “Generation of a cell line derived gene signature predictor of response to Doxorubicin in Diffuse Large B-Cell Lymphoma” and Liesbeth’s poster title was “Combination of the IGF-1 receptor inhibitor picropodophyllin (PPP) and the BH3 mimetic ABT-737 has synergistic anti-myeloma activity”, for which she received the best poster presentation award.
23 January 2013
Maria RD, Anders, Steffen and Martin attended a conference at VU University, Amsterdam, on 24-25 January 2013, SMPDG (statistical methods for (post)-Genomics Data, see www.smpgd2013.nl.
Anders gave an oral presentation with the title “Reproducibility of high-throughput experimental results”.
Maria, Steffen and Martin presented posters with the titles “Reproducible probe-level analysis of Affymetrix’s exon array with R/Bioconductor”, “Generation of a Cell Line Derived Gene Signature Predictor of Response to Doxorubicin in Diffuse Large B-Cell Lymphoma” and “A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells”, respectively.
1 March 2013
At the 28th Annual General Meeting of the Belgian Hematological Society (Ghent, 24 to 26 January 2013), Liesbeth Bieghs received an award for her poster presentation titled “The IGF-1 receptor inhibitor picropodophyllin (PPP) potentiates the anti-myeloma effects of the BH3 mimetic ABT-737 “.
Liesbeth Bieghs is a Joint PhD student at our department and at the Hematology department of the VUB in Belgium.
23 January 2013
Sara Marques attended a PhD course at the University of Coimbra, Portugal, entitled Introduction to Pharmacogenomics – clinical applications.
This course introduced the students to the basic concepts of the field that aims at finding the right therapeutic approach for each patient according to their genetic profile.
Current clinical applications and projects that are expected to lead to future recommendations are presented, from cancer and neurodegenerative diseases to heart and mental health disorders, among others.
Students were actively involved in the course through paper discussions.
1 September 2012
The annual haematological harvest meeting will be held in Aalborg on 21 September 2012.
Please find the programme here
20 January 2013
Sara and Steffen attended the PhD Day of the Graduate School of Health of the Aarhus University.
Under the theme “Future talent – future challenge”, the audience heard and participated in the discussion regarding the challenges they should be prepared to face in the years ahead. PhD and Research year students presented their projects in oral communications or posters.
Sara presented the poster “Functional analysis of microRNA-dependent chemosensitivity in B-cell cancers by lentiviral transduction in human cancer B-cell lines” and Steffen’s poster was entitled “Drug exposure time independent summary statistics for cell line based drug response studies”.
1 December 2012
Associated Professor Karen Dybkær and PhD student Liesbeth Bieghs will attend the Annual Meeting at Atlanta.
Karen Dybkær has had 2 abstracts accepted:
Liesbeth Bieghs has had one abstract accepted: